3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
49
Burkitt Lymphoma
28
Leukemia, Biphenotypic, Acute
16
Leukemia, Myeloid, Acute
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Leukemia
10
Myelodysplastic Syndromes
9
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma
6
Leukemia, Myeloid, Accelerated Phase
6
Blast Crisis
6
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Graft vs Host Disease
5
Osteosarcoma
4
Medulloblastoma
4
Down Syndrome
4
Urinary Bladder Neoplasms
3
Recurrence
3
Primary Myelofibrosis
3
Neoplasm Metastasis
3
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Juvenile
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Thrombocythemia, Essential
2
Rhabdoid Tumor
2
Polycythemia Vera
2
Interventions
neurotropin
1
haloperidol decanoate
1
fludarabine phosphate
1
fludarabine
1
axicabtagene ciloleucel
1
Temozolomide
1
Tadalafil
1
Surveys and Questionnaires
1
Simvastatin
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Nutritional Status
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Lorazepam
1
Interleukin 1 Receptor Antagonist Protein
1
Exercise Therapy
1
Exercise
1
Dexamethasone
1
Cyclophosphamide
1
Bendamustine Hydrochloride
1
AP 1903 reagent
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurotoxicity Syndromes
×
Methotrexate
×
1 year
×
Clear all
No trials found.